Skip to main content
JOHNSON & JOHNSON logo

JOHNSON & JOHNSON — Investor Relations & Filings

Ticker · JNJ ISIN · US4781601046 LEI · 549300G0CFPGEF6X2043 US Manufacturing
Filings indexed 3,096 across all filing types
Latest filing 2026-04-22 Interim / Quarterly Rep…
Country US United States of America
Listing US JNJ

About JOHNSON & JOHNSON

https://www.jnj.com/

Johnson & Johnson is a healthcare company that operates through two primary segments: Innovative Medicine and MedTech. The Innovative Medicine division is focused on the research, development, and delivery of new treatments for complex diseases in areas such as oncology, immunology, neuroscience, and cardiopulmonary conditions. The MedTech segment develops and provides a broad portfolio of medical technologies and solutions. It innovates in fields including surgery, orthopaedics, vision, and interventional solutions, aiming to create smarter, less invasive, and more personalized healthcare treatments. The company's mission is to address significant health challenges through science-based innovation at the intersection of biology and technology.

Recent filings

Filing Released Lang Actions
10-Q - JOHNSON & JOHNSON (0000200406) (Filer)
Interim / Quarterly Report
2026-04-22 English
8-K - JOHNSON & JOHNSON (0000200406) (Filer)
Regulatory Filings
2026-04-14 English
SCHEDULE 13G/A - JOHNSON & JOHNSON (0000200406) (Subject)
Major Shareholding Notification
2026-03-26 English
13F-HR/A - JOHNSON & JOHNSON (0000200406) (Filer)
Regulatory Filings
2026-03-18 English
13F-HR/A - JOHNSON & JOHNSON (0000200406) (Filer)
Regulatory Filings
2026-03-18 English
4 - JOHNSON & JOHNSON (0000200406) (Filer)
Director's Dealing
2026-03-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.